Primary Care POC Diagnostics Global Market Report 2024

Description

A point-of-care (POC) diagnostic in primary care entails conducting medical tests or evaluations conveniently and swiftly within a primary care environment, such as a doctor's office or clinic, without the need for specialized equipment or extensive laboratory processing. These diagnostics aim to deliver prompt results, enabling healthcare providers to make timely decisions regarding patient care during the initial consultation.

Primary care POC diagnostics encompass a range of products, including glucose monitoring, cardiometabolic testing products, infectious disease testing products, coagulation testing products, pregnancy and fertility testing products, tumor or cancer marker testing products, cholesterol testing products, hematology testing products, drug-of-abuse (DOA) testing products, among others. Glucose monitoring involves measuring blood glucose levels to manage diabetes and is available in different types such as prescription-based and over-the-counter (OTC) testing. These are utilized across various settings, including hospitals, diagnostic centers, research laboratories, home-care settings, and others.

The primary care POC diagnostics market research report is one of a series of new reports from The Business Research Company that provides primary care POC diagnostics market statistics, including primary care POC diagnostics industry global market size, regional shares, competitors with a primary care POC diagnostics market share, detailed primary care POC diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the primary care POC diagnostics industry. This primary care POC diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The primary care POC diagnostics market size has grown strongly in recent years. It will grow from $15.32 billion in 2023 to $16.46 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth observed in the historical period can be ascribed to several factors, including the rising prevalence of chronic diseases, a shift towards personalized medicine, increased healthcare spending, the implementation of supportive regulatory frameworks, streamlined approval processes, and a heightened focus on early disease detection and prevention strategies.

The primary care POC diagnostics market size is expected to see strong growth in the next few years. It will grow to $22.19 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. the anticipated growth in the forecast period can be attributed to various factors such as the emergence of infectious disease outbreaks, the expanding use of POC diagnostics in non-communicable diseases, greater adoption in home healthcare settings, advancements in precision medicine initiatives, augmented investments in healthcare infrastructure, escalating disease burden, and heightened awareness regarding the significance of early disease detection. Key trends expected in the forecast period include the integration of artificial intelligence (AI) and machine learning algorithms, advancements in molecular diagnostics technologies, the miniaturization and enhanced portability of POC diagnostic devices, the integration of smart devices, and the utilization of multiplexing and panel testing in POC diagnostics.

The anticipated increase in infectious diseases is poised to drive the expansion of the primary care POC diagnostics market in the foreseeable future. Infectious diseases, caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, spread through direct or indirect contact with contaminated surfaces, air, water, or vectors such as insects. Factors contributing to their prevalence include poor environmental conditions, urbanization, antimicrobial resistance, and insufficient vaccination coverage. Primary care POC diagnostics play a crucial role in addressing this rise in infectious diseases by enabling early detection, timely treatment, and effective disease control across various healthcare settings. For example, in October 2023, a report from the UK Health Security Agency revealed a 22% increase in HIV diagnoses in England from 3,118 in 2021 to 3,805 in 2022. Additionally, in November 2023, the World Health Organization reported approximately 10.6 million cases of tuberculosis globally in 2022, affecting millions across different demographics. Thus, the surge in infectious diseases is propelling the primary care POC diagnostics market forward.

Leading companies in the primary care POC diagnostics market are concentrating on advanced technological solutions, such as portable point-of-care RT-PCR systems, to optimize their market revenue. These systems, designed for real-time reverse transcription polymerase chain reaction (RT-PCR) tests outside traditional laboratories, offer mobility and compactness. For instance, Genes2Me Pvt. Ltd. introduced the Rapi-Q Point of Care RT PCR solution in October 2022, featuring an eight-well block design with four fluorescent channels, claimed to deliver rapid results in under 45 minutes. Portable and lightweight, the Rapi-Q system is suitable for various settings such as hospitals, blood banks, health clinics, research laboratories, and airports. It boasts high sensitivity, accuracy, and performance in disease detection, compatible with over 50 lyophilized, room-temperature disease detection kits.

In February 2021, Thermo Fisher Scientific Inc., a US-based biotechnology firm, acquired Mesa Biotech Inc. for about $450 million, bolstering its molecular diagnostics capabilities, particularly in POC testing, and enhancing its portfolio of infectious disease diagnostic solutions. Mesa Biotech Inc., a US-based molecular diagnostic company, specializes in primary care point-of-care tests and platforms.

Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

North America was the largest region in the primary care POC diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the primary care POC diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary care POC diagnostics market consists of sales of respiratory pathogen testing products, thyroid function testing products, electrolyte testing products, and liver function testing products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Primary Care POC Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on primary care POC diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for primary care POC diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The primary care POC diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Glucose Monitoring; Cardiometabolic Testing Products; Infectious Disease Testing Products; Coagulation Testing Products; Pregnancy And Fertility Testing Products; Tumor Or Cancer Marker Testing Products; Cholesterol Testing Products; Hematology Testing Products; Drug-Of-Abuse (DOA) Testing Products; Other Products
2) By Prescription: Prescription Based; Over-The-Counter (OTC) Testing
3) By End-Use: Hospitals; Diagnostic Centers; Research Laboratories; Home-Care Settings; Other End-Uses
Companies Mentioned: Hoffmann-La Roche Ltd; Abbott Laboratories; Siemens Healthineers AG; Becton, Dickinson And Company; bioMerieux SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18208

1. Executive Summary

2. Primary Care POC Diagnostics Market Characteristics

3. Primary Care POC Diagnostics Market Trends And Strategies

4. Primary Care POC Diagnostics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Primary Care POC Diagnostics Market Size and Growth

5.1. Global Primary Care POC Diagnostics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Primary Care POC Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Primary Care POC Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Primary Care POC Diagnostics Market Segmentation

6.1. Global Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Glucose Monitoring
Cardiometabolic Testing Products
Infectious Disease Testing Products
Coagulation Testing Products
Pregnancy And Fertility Testing Products
Tumor Or Cancer Marker Testing Products
Cholesterol Testing Products
Hematology Testing Products
Drug-Of-Abuse (DOA) Testing Products
Other Products
6.2. Global Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Prescription Based
Over-The-Counter (OTC) Testing
6.3. Global Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Diagnostic Centers
Research Laboratories
Home-Care Settings
Other End-Uses

7. Primary Care POC Diagnostics Market Regional And Country Analysis

7.1. Global Primary Care POC Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Primary Care POC Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Primary Care POC Diagnostics Market

8.1. Asia-Pacific Primary Care POC Diagnostics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Primary Care POC Diagnostics Market

9.1. China Primary Care POC Diagnostics Market Overview
9.2. China Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Primary Care POC Diagnostics Market

10.1. India Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Primary Care POC Diagnostics Market

11.1. Japan Primary Care POC Diagnostics Market Overview
11.2. Japan Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Primary Care POC Diagnostics Market

12.1. Australia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Primary Care POC Diagnostics Market

13.1. Indonesia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Primary Care POC Diagnostics Market

14.1. South Korea Primary Care POC Diagnostics Market Overview
14.2. South Korea Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Primary Care POC Diagnostics Market

15.1. Western Europe Primary Care POC Diagnostics Market Overview
15.2. Western Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Primary Care POC Diagnostics Market

16.1. UK Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Primary Care POC Diagnostics Market

17.1. Germany Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Primary Care POC Diagnostics Market

18.1. France Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Primary Care POC Diagnostics Market

19.1. Italy Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Primary Care POC Diagnostics Market

20.1. Spain Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Primary Care POC Diagnostics Market

21.1. Eastern Europe Primary Care POC Diagnostics Market Overview
21.2. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Primary Care POC Diagnostics Market

22.1. Russia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Primary Care POC Diagnostics Market

23.1. North America Primary Care POC Diagnostics Market Overview
23.2. North America Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Primary Care POC Diagnostics Market

24.1. USA Primary Care POC Diagnostics Market Overview
24.2. USA Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Primary Care POC Diagnostics Market

25.1. Canada Primary Care POC Diagnostics Market Overview
25.2. Canada Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Primary Care POC Diagnostics Market

26.1. South America Primary Care POC Diagnostics Market Overview
26.2. South America Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Primary Care POC Diagnostics Market

27.1. Brazil Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Primary Care POC Diagnostics Market

28.1. Middle East Primary Care POC Diagnostics Market Overview
28.2. Middle East Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Primary Care POC Diagnostics Market

29.1. Africa Primary Care POC Diagnostics Market Overview
29.2. Africa Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Primary Care POC Diagnostics Market Competitive Landscape And Company Profiles

30.1. Primary Care POC Diagnostics Market Competitive Landscape
30.2. Primary Care POC Diagnostics Market Company Profiles
- 30.2.1. Hoffmann-La Roche Ltd
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Abbott Laboratories
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Siemens Healthineers AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Becton, Dickinson And Company
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. bioMerieux SA
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Primary Care POC Diagnostics Market Other Major And Innovative Companies

31.1. Quidel Corporation
31.2. Sysmex Corporation
31.3. Bio-Rad Laboratories Inc.
31.4. Nova Biomedical Corporation
31.5. Randox Laboratories Ltd
31.6. Ortho Clinical Diagnostics
31.7. Nipro Corporation
31.8. OraSure Technologies
31.9. Meridian Bioscience Inc
31.10. DiaSorin SpA
31.11. Sekisui Diagnostics LLC
31.12. EKF Diagnostics Holdings plc
31.13. Trinity Biotech plc
31.14. Fujirebio Diagnostics Inc.
31.15. Immunodiagnostic Systems Holdings PLC

32. Global Primary Care POC Diagnostics Market Competitive Benchmarking

33. Global Primary Care POC Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Primary Care POC Diagnostics Market

35. Primary Care POC Diagnostics Market Future Outlook and Potential Analysis

35.1 Primary Care POC Diagnostics Market In 2028 - Countries Offering Most New Opportunities
35.2 Primary Care POC Diagnostics Market In 2028 - Segments Offering Most New Opportunities
35.3 Primary Care POC Diagnostics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer